| P2093 | author name string | R Roberts | |
| | N S Kleiman | |
| | M S Verani | |
| | A E Raizner | |
| | J K Dunn | |
| | S T Minor | |
| | U Marzoll | |
| P2860 | cites work | Intracoronary thrombolytic therapy in acute myocardial infarction: a prospective, randomized, controlled trial | Q69938277 |
| | Evolution of left ventricular function after intracoronary thrombolysis for acute myocardial infarction | Q69950871 |
| | A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction | Q69989563 |
| | A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty | Q70041641 |
| | Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study | Q70316987 |
| | The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial | Q70331348 |
| | Influence of baseline ejection fraction and success of thrombolysis on mortality and ventricular function after acute myocardial infarction | Q70635823 |
| | Return of left ventricular function after reperfusion in patients with myocardial infarction: importance of subtotal stenoses or intact collaterals | Q71250449 |
| | Salvage of myocardial function by coronary artery reperfusion 1, 2, and 3 hours after occlusion in conscious dogs | Q71822541 |
| | Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data | Q72561659 |
| | Discrepancies between the effects of coronary reperfusion on survival and left ventricular function | Q38352395 |
| | A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction | Q41783750 |
| | Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience | Q42082355 |
| | Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). | Q43422779 |
| | Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial | Q44352898 |
| | Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands | Q44374456 |
| | Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival | Q47211077 |
| | The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs | Q47325541 |
| | Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. | Q52534547 |
| | Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. | Q54135542 |
| | Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction | Q61651578 |
| | Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial | Q67286885 |
| | Influence of acute alterations in heart rate and systemic arterial pressure on echocardiographic measures of left ventricular perfornmance in normal human subjects | Q67314141 |
| | Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival | Q68437795 |
| | Direct coronary angioplasty in acute myocardial infarction: outcome in patients with single vessel disease | Q68709033 |
| | Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction | Q69183950 |
| | Medical and surgical management of early Q wave myocardial infarction. II. Effects on mortality and global and regional left ventricular function at 10 or more years of follow-up | Q69639958 |
| | Effect of thrombolysis (streptokinase) on left ventricular function during acute myocardial infarction | Q69653947 |
| | Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction (results from the ISAM study) | Q69768230 |
| | Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction | Q69905443 |
| | Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty | Q69912387 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ejection fraction | Q641303 |
| | myocardial infarction | Q12152 |
| | acute myocardial infarction | Q18558122 |
| P304 | page(s) | 613-620 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Factors determining improvement in left ventricular function after reperfusion therapy for acute myocardial infarction: primacy of baseline ejection fraction | |
| P478 | volume | 17 | |